NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy P. KellyChief Technology Officer2026-02-256,228$1.93
$12.02kSell
Tina M. AlbertsonChief Medical Officer2026-02-241,066$1.96
$2.09kSell
Timothy P. KellyChief Technology Officer2026-02-243,147$1.96
$6.17kSell
Ruhi Ahmad KhanChief Business Officer2026-02-246,938$1.96
$13.60kSell
Barbara G. McClungChief Legal Officer2026-02-246,938$1.96
$13.60kSell

1 of 1

CRBU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rachel E. Haurwitz3.56%3,816,545$4.92MInsider
Fmr LLC3.10%3,323,284$4.29MInsider
Barbara G. McClung0.45%481,564$621.22kInsider
Steven Kanner0.40%431,556$556.71kInsider
Ryan Fischesser0.11%118,854$153.32kInsider
Ruhi Ahmad Khan0.10%104,998$135.45kInsider
Timothy P. Kelly0.07%73,125$94.33kInsider
Sriram Ryali0.07%72,360$93.34kInsider
Tina M. Albertson0.06%68,523$88.39kInsider
Syed Aliaamir Rizvi0.06%59,373$76.59kInsider

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU0.05%8.03%Net Selling
CRBP0.07%76.94%Net SellingNet Selling
ADCT0.06%43.59%Net Selling
LENZ0.11%93.63%Net Selling
UNCY0.04%16.43%

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 0.05% institutional shareholders, 8.03% Caribou Biosciences insiders, and 91.92% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.82M shares representing 3.56% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $4.85M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.